4-(3-溴苯基磺酰)吗啉 | 871269-13-5

• 物质功能分类: 原料药 - 人工合成抗感染类药 - 磺胺类药及增效剂
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(3-溴苯基磺酰)吗啉
• 中文别名: 4-(3-溴苯基磺酰基)吗啉
• 英文名称: 4-((3-bromophenyl)sulfonyl)morpholine
• 英文别名: 4-(3-Bromophenylsulfonyl)morpholine；4-(3-bromophenyl)sulfonylmorpholine
• CAS: 871269-13-5
• 化学式: C₁₀H₁₂BrNO₃S
• mdl: MFCD07363828
• 分子量: 306.18
• InChiKey: BMAMBBTZMVECJZ-UHFFFAOYSA-N

物化性质

• 熔点：
  132-136

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  55
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2934999090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
4-(3-Bromophenylsulfonyl)morpholine
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
4-(3-Bromophenylsulfonyl)morpholine
Ingredient name:
CAS number: 871269-13-5

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H12BrNO3S
Molecular weight: 306.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(3-溴苯基磺酰)吗啉 在 tris-(dibenzylideneacetone)dipalladium(0) 、 caesium carbonate 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 、 三氟乙酸 作用下， 以 1,4-二氧六环 、 异丙醇 为溶剂， 反应 21.0h， 生成 5-methyl-N2-(4-(3-morpholinopropoxy)phenyl)-N4-(3-(morpholinosulfonyl)phenyl)pyrimidine-2,4-diamine
  参考文献：
  名称：

  [EN] NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA
  [FR] NOUVEAUX COMPOSÉS ET TRAITEMENT DU CARCINOME À CELLULES RÉNALES

  摘要：

  There is provided a compound according to formula (I) or a pharmaceutically acceptable salt or prodrug thereof.

  公开号：

  WO2023166153A1
• 作为产物：
  描述：

  1-溴-3-碘苯 在 sodium hypochlorite 、 双(二氧化硫)-1,4-二氮杂双环[2.2.2]辛烷加合物 、 palladium diacetate 、 正丁基二(1-金刚烷基)膦 作用下， 以 水 、 异丙醇 为溶剂， 反应 17.5h， 生成 4-(3-溴苯基磺酰)吗啉
  参考文献：
  名称：

  利用钯催化芳基碘硫化的一锅磺酰胺合成

  摘要：

  芳基亚磺酸铵，方便地由芳基碘化物和二氧化硫替代物 DABSO 制备，在钯 (0) 催化剂的作用下，在一锅法中转化为各种功能化的磺酰胺。亚磺酸盐向磺酰胺的转化是通过用相关胺和次氯酸钠（漂白剂）的水溶液进行简单处理来实现的。广泛的胺，包括苯胺和氨基酸衍生物，可与各种芳基碘有效结合，产生高产率的磺胺类药物。

  DOI：

  10.1055/s-0035-1560578

文献信息

• Radical Carbonyl Umpolung Arylation via Dual Nickel Catalysis
  作者：Huan-Ming Huang、Peter Bellotti、Johannes E. Erchinger、Tiffany O. Paulisch、Frank Glorius

  DOI：10.1021/jacs.1c12199

  日期：2022.2.2

  This redox-neutral approach provides a complementary method to construct Grignard-type products from (hetero)aryl bromides and aliphatic aldehydes, without the need for pre-functionalization. A sequential activation, hydrogen-atom transfer, and halogen atom transfer process could directly convert aldehydes to the corresponding ketyl-type radicals, which further react with aryl-nickel intermediates in

  碳-碳键的形成是合成有机化学的核心，广泛应用于构建复杂的药物、聚合物和材料。尽管它很重要，但由于范围和官能团耐受性有限，催化羰基芳基化仍然相对不发达。在此，我们公开了一种通过双催化实现自由基羰基芳基化的 umpolung 策略。这种氧化还原中性方法提供了一种补充方法，可以从（杂）芳基溴化物和脂肪醛构建格氏型产品，而无需预功能化。顺序活化、氢原子转移和卤素原子转移过程可以直接将醛转化为相应的酮基型自由基，在整个极性反转过程中进一步与芳基镍中间体反应。
• Acetylenyl-pyrazolo-pyrimidine derivatives
  申请人：McArthur Gatti Silvia

  公开号：US20060217387A1

  公开（公告）日：2006-09-28

  The present invention relates to compounds of formula (I): wherein R 1 to R 3 , A, M, L, E, G, and J are as defined in the description and claims. The invention also relates to a process for the manufacture of such compounds, pharmaceutical compositions containing them, and methods for treating CNS disorders.

  本发明涉及式(I)的化合物：其中R1到R3、A、M、L、E、G和J的定义如描述和索赔中所述。该发明还涉及一种制备此类化合物的方法、含有它们的药物组合物，以及治疗中枢神经系统疾病的方法。
• Site‐Selective 1,2‐Dicarbofunctionalization of Vinyl Boronates through Dual Catalysis
  作者：Shang‐Zheng Sun、Yaya Duan、Riccardo S. Mega、Rosie J. Somerville、Ruben Martin

  DOI：10.1002/anie.201916279

  日期：2020.3.9

  A modular, site-selective 1,2-dicarbofunctionalization of vinyl boronates with organic halides through dual catalysis is described. This reaction proceeds under mild conditions and is characterized by excellent chemo- and regioselectivity. It thus represents a complementary new technique for preparing densely functionalized alkyl boron architectures from simple and accessible precursors.

  描述了通过双重催化将硼酸乙烯基酯与有机卤化物进行模块化，位置选择性的1,2-二苯官能化。该反应在温和的条件下进行，并具有出色的化学选择性和区域选择性。因此，它代表了一种补充性新技术，该技术可用于从简单易接近的前体制备致密官能化的烷基硼结构。
• Direct Copper-Catalyzed Three-Component Synthesis of Sulfonamides
  作者：Yiding Chen、Philip R. D. Murray、Alyn T. Davies、Michael C. Willis

  DOI：10.1021/jacs.8b04532

  日期：2018.7.18

  Despite their popularity in the design of modern bioactive molecules, the underpinning methods for sulfonamide synthesis are essentially unchanged since their introduction, and rely on the use of starting materials with preinstalled sulfur-functionality. Herein we report a direct single-step synthesis of sulfonamides that combines two of the largest monomer sets available in discovery chemistry, (hetero)aryl

  磺胺官能团于 1930 年代首次引入药物中，继续存在于广泛的当代药物和农用化学品中。尽管它们在现代生物活性分子的设计中很受欢迎，但磺酰胺合成的基础方法自引入以来基本上没有变化，并且依赖于使用具有预装硫官能团的起始材料。在此，我们报告了磺酰胺的直接单步合成，该合成结合了发现化学中可用的两个最大的单体组，（杂）芳基硼酸和胺，以及二氧化硫，使用 Cu(II) 催化剂，以提供广泛的一系列磺胺类药物。二氧化硫由替代试剂 DABSO 提供。该反应容忍两种偶联伙伴的广泛变化，包括芳基、杂芳基和烯基硼酸，以及环状和无环烷基仲胺和伯苯胺。我们通过证明可以将各种药物和药物片段纳入该过程来验证该方法。
• Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
  申请人：Rodgers D. James

  公开号：US20070135461A1

  公开（公告）日：2007-06-14

  The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

  本发明提供了杂环取代的吡咯并[2,3-b]吡啶和杂环取代的吡咯并[2,3-b]嘧啶，可以调节雅努斯激酶的活性，并且在治疗与雅努斯激酶活性相关的疾病中具有用处，例如免疫相关疾病、皮肤疾病、髓增生性疾病、癌症和其他疾病。